Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07763236
Indocyanine Green Fluorescence in Endoscopic Resection of Non-Functioning Pituitary AdenomasTomislav FelbabićCompletedNot Applicable
NCT07763236Completed
Not Applicable
Indocyanine Green Fluorescence in Endoscopic Resection of Non-Functioning Pituit...Tomislav Felbabić
NCT07764120
Quality of Life of Patients After Rectal Cancer Resection .University Hospital, GrenobleNot Yet Recruiting
NCT07764120Not Yet Recruiting
—
Quality of Life of Patients After Rectal Cancer Resection .University Hospital, Gren...
NCT07764003
A Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Response to 2nd-generation H1-AHsHangzhou Highlightll Pharmaceutical Co., LtdNot Yet RecruitingPhase 2
NCT07764003Not Yet Recruiting
Phase 2
A Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Re...Hangzhou Highlightll Phar...
NCT07762118
Brain Stimulation Paired With Structured Language Learning in AdultsGeneral Neuro Inc.RecruitingNot Applicable
NCT07762118Recruiting
Not Applicable
Brain Stimulation Paired With Structured Language Learning in AdultsGeneral Neuro Inc.
NCT07763353
Effects of Slow-paced Breathing on Heart Rate Variability in Patients With Heart FailureChung Shan Medical UniversityNot Yet RecruitingNot Applicable
NCT07763353Not Yet Recruiting
Not Applicable
Effects of Slow-paced Breathing on Heart Rate Variability in Patients With Heart...Chung Shan Medical Univer...
NCT07762443
A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia AreataJiangsu vcare pharmaceutical technology co., LTDNot Yet RecruitingPhase 1
NCT07762443Not Yet Recruiting
Phase 1
A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Are...Jiangsu vcare pharmaceuti...
NCT07762716
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyBreakBio CorpNot Yet RecruitingPhase 1
NCT07762716Not Yet Recruiting
Phase 1
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTr...BreakBio Corp
NCT07762391
Pelvic Floor Muscle Exercise and Progressive Muscle Relaxation for Stress Urinary IncontinenceKaramanoğlu Mehmetbey UniversityCompletedNot Applicable
NCT07762391Completed
Not Applicable
Pelvic Floor Muscle Exercise and Progressive Muscle Relaxation for Stress Urinar...Karamanoğlu Mehmetbey Uni...
NCT07762872
A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSDChifeng Municipal HospitalRecruiting
NCT07762872Recruiting
—
A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in...Chifeng Municipal Hospita...
NCT07763756
Single vs Multiple Injection Intertransverse Process Block in Breast Cancer SurgeryAntalya City HospitalNot Yet RecruitingNot Applicable
NCT07763756Not Yet Recruiting
Not Applicable
Single vs Multiple Injection Intertransverse Process Block in Breast Cancer Surg...Antalya City Hospital
NCT07762209
Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With HPVAdknoma Health ResearchNot Yet RecruitingNot Applicable
NCT07762209Not Yet Recruiting
Not Applicable
Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With HPVAdknoma Health Research
NCT07762963
Turkish Validation of the Core Life Activities ScaleTokat Gaziosmanpasa UniversityNot Yet Recruiting
NCT07762963Not Yet Recruiting
—
Turkish Validation of the Core Life Activities ScaleTokat Gaziosmanpasa Unive...
NCT07762664
Photon-Counting CT Versus Conventional CT for Carotid Plaque Assessment in Patients With Carotid Artery StenosisChinese PLA General HospitalRecruiting
NCT07762664Recruiting
—
Photon-Counting CT Versus Conventional CT for Carotid Plaque Assessment in Patie...Chinese PLA General Hospi...
NCT07763964
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fed Study.ADIUMCompletedNot Applicable
NCT07763964Completed
Not Applicable
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitag...ADIUM
NCT07763262
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha UniversityCompletedNot Applicable
NCT07763262Completed
Not Applicable
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha University
NCT07763847
Effect of Elagolix in Symptomatic Endometrioma in Comparison to Combined Oral Contraceptive Pill.Mst.Sumyara KhatunCompletedNot Applicable
NCT07763847Completed
Not Applicable
Effect of Elagolix in Symptomatic Endometrioma in Comparison to Combined Oral Co...Mst.Sumyara Khatun
NCT07762274
The RenAtt Method for Diagnosing and Treating Attention Problems After Stroke and Brain Injury, Further Validation of RehAtt® DiSTRO Assessment of Cognitive and Visual FunctionDepartment of clinical sciences at Danderyd hospitalCompleted
NCT07762274Completed
—
The RenAtt Method for Diagnosing and Treating Attention Problems After Stroke an...Department of clinical sc...
NCT07762066
Bridge to Belonging: Peer Led Intervention to Reduce Loneliness and Depression Among Older Gay and Bisexual MenFenway Community HealthRecruitingNot Applicable
NCT07762066Recruiting
Not Applicable
Bridge to Belonging: Peer Led Intervention to Reduce Loneliness and Depression A...Fenway Community Health
NCT07763171
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-negative and PD-L1 TAP Score of 5 or More Advanced Gastroesophageal AdenocarcinomaGruppo Oncologico del Nord-OvestNot Yet RecruitingPhase 3
NCT07763171Not Yet Recruiting
Phase 3
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-neg...Gruppo Oncologico del Nor...
NCT07764146
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's DiseaseVoyager TherapeuticsNot Yet RecruitingPhase 1
NCT07764146Not Yet Recruiting
Phase 1
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheim...Voyager Therapeutics
Result Breakdown
Not yet recruiting10 (50%)
Completed6 (30%)
Recruiting4 (20%)
not_applicable10 (50%)
Not Specified5 (25%)
Phase 13 (15%)
Phase 21 (5%)
Phase 31 (5%)